Literature DB >> 18188448

Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice.

Jianhe Huang1, Lan Cheng, Jian Li, Mary Chen, Deying Zhou, Min Min Lu, Aaron Proweller, Jonathan A Epstein, Michael S Parmacek.   

Abstract

Myocardin (Myocd) is a potent transcriptional coactivator that has been implicated in cardiovascular development and adaptation of the cardiovascular system to hemodynamic stress. To determine the function of myocardin in the developing cardiovascular system, Myocd(F/F)/Wnt1-Cre(+) and Myocd(F/F)/Pax3-Cre(+) mice were generated in which the myocardin gene was selectively ablated in neural crest-derived SMCs populating the cardiac outflow tract and great arteries. Both Myocd(F/F)/Wnt1-Cre(+) and Myocd(F/F)/Pax3-Cre(+) mutant mice survived to birth, but died prior to postnatal day 3 from patent ductus arteriosus (PDA). Neural crest-derived SMCs populating the ductus arteriosus (DA) and great arteries exhibited a cell autonomous block in expression of myocardin-regulated genes encoding SMC-restricted contractile proteins. Moreover, Myocd-deficient vascular SMCs populating the DA exhibited ultrastructural features generally associated with the SMC synthetic, rather than contractile, phenotype. Consistent with these findings, ablation of the Myocd gene in primary aortic SMCs harvested from Myocd conditional mutant mice caused a dramatic decrease in SMC contractile protein expression. Taken together, these data demonstrate that myocardin regulates expression of genes required for the contractile phenotype in neural crest-derived SMCs and provide new insights into the molecular and genetic programs that may underlie PDA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18188448      PMCID: PMC2176191          DOI: 10.1172/JCI33304

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Voltage-gated potassium channels in human ductus arteriosus.

Authors:  E Michelakis; I Rebeyka; J Bateson; P Olley; L Puttagunta; S Archer
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

2.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.

Authors:  Bart L Loeys; Junji Chen; Enid R Neptune; Daniel P Judge; Megan Podowski; Tammy Holm; Jennifer Meyers; Carmen C Leitch; Nicholas Katsanis; Neda Sharifi; F Lauren Xu; Loretha A Myers; Philip J Spevak; Duke E Cameron; Julie De Backer; Jan Hellemans; Yan Chen; Elaine C Davis; Catherine L Webb; Wolfram Kress; Paul Coucke; Daniel B Rifkin; Anne M De Paepe; Harry C Dietz
Journal:  Nat Genet       Date:  2005-01-30       Impact factor: 38.330

3.  Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor.

Authors:  D Wang; P S Chang; Z Wang; L Sutherland; J A Richardson; E Small; P A Krieg; E N Olson
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

4.  GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis.

Authors:  John J Lepore; Patricia A Mericko; Lan Cheng; Min Min Lu; Edward E Morrisey; Michael S Parmacek
Journal:  J Clin Invest       Date:  2006-03-23       Impact factor: 14.808

5.  Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation.

Authors:  Jiyeon Oh; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-04       Impact factor: 11.205

6.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

7.  Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles.

Authors:  Giuseppe Testa; Youming Zhang; Kristina Vintersten; Vladimir Benes; W W M Pim Pijnappel; Ian Chambers; Andrew J H Smith; Austin G Smith; A Francis Stewart
Journal:  Nat Biotechnol       Date:  2003-03-10       Impact factor: 54.908

8.  Targeted oncogene activation by site-specific recombination in transgenic mice.

Authors:  M Lakso; B Sauer; B Mosinger; E J Lee; R W Manning; S H Yu; K L Mulder; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

9.  Ductus arteriosus responses to prostaglandin E1 at high and low oxygen concentrations.

Authors:  R I Clyman; M A Heymann; A M Rudolph
Journal:  Prostaglandins       Date:  1977-02

10.  Myocardin: a component of a molecular switch for smooth muscle differentiation.

Authors:  Jiyuan Chen; Chad M Kitchen; Jeffrey W Streb; Joseph M Miano
Journal:  J Mol Cell Cardiol       Date:  2002-10       Impact factor: 5.000

View more
  73 in total

1.  Characterization of Pax3-expressing cells from adult blood vessels.

Authors:  Olivier Goupille; Giorgia Pallafacchina; Frédéric Relaix; Simon J Conway; Ana Cumano; Benoit Robert; Didier Montarras; Margaret Buckingham
Journal:  J Cell Sci       Date:  2011-12-08       Impact factor: 5.285

2.  A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.

Authors:  Christina Pagiatakis; Joseph W Gordon; Saviz Ehyai; John C McDermott
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

3.  Ca2+/calmodulin-dependent protein kinase II-γ (CaMKIIγ) negatively regulates vascular smooth muscle cell proliferation and vascular remodeling.

Authors:  Fatima Z Saddouk; Li-Yan Sun; Yong Feng Liu; Miao Jiang; Diane V Singer; Johannes Backs; Dee Van Riper; Roman Ginnan; John J Schwarz; Harold A Singer
Journal:  FASEB J       Date:  2015-11-13       Impact factor: 5.191

4.  Myocardin: new therapeutic agent in vascular disease?

Authors:  Xiaochun Long; Joseph M Miano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10       Impact factor: 8.311

Review 5.  Regulation of cardiac myocyte cell death and differentiation by myocardin.

Authors:  Joseph W Gordon
Journal:  Mol Cell Biochem       Date:  2017-06-19       Impact factor: 3.396

6.  CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation.

Authors:  Ping Xie; Yongna Fan; Hua Zhang; Yuan Zhang; Mingpeng She; Dongfeng Gu; Cam Patterson; Huihua Li
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

7.  Myocardin Is Involved in Mesothelial-Mesenchymal Transition of Human Pleural Mesothelial Cells.

Authors:  Torry Tucker; Yoshikazu Tsukasaki; Tsuyoshi Sakai; Shinya Mitsuhashi; Satoshi Komatsu; Ann Jeffers; Steven Idell; Mitsuo Ikebe
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

8.  Myocardin is sufficient for a smooth muscle-like contractile phenotype.

Authors:  Xiaochun Long; Robert D Bell; William T Gerthoffer; Berislav V Zlokovic; Joseph M Miano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

9.  Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression.

Authors:  Jianbin Huang; Elaine C Davis; Shelby L Chapman; Madhusudhan Budatha; Lihua Y Marmorstein; R Ann Word; Hiromi Yanagisawa
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

10.  A rare human sequence variant reveals myocardin autoinhibition.

Authors:  Joshua F Ransom; Isabelle N King; Vidu Garg; Deepak Srivastava
Journal:  J Biol Chem       Date:  2008-10-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.